ADVM - Adverum Biotechnologies, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,8491,4552,319572
Cost of Revenue39,83930,27025,46216,976
Gross Profit-37,990-28,815-23,143-16,404
Operating Expenses
Research Development----
Selling General and Administrative20,85720,35519,7077,998
Non Recurring----
Total Operating Expenses60,69650,62545,16924,974
Operating Income or Loss-58,847-49,170-42,850-24,402
Income from Continuing Operations
Total Other Income/Expenses Net2,700-65,352-4,603-1,002
Earnings Before Interest and Taxes-58,847-49,170-42,850-24,402
Interest Expense----18
Income Before Tax-56,147-114,522-47,453-25,404
Income Tax Expense--775--
Minority Interest----
Net Income From Continuing Ops-56,147-113,747-47,453-25,404
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-56,147-113,747-47,453-25,404
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-56,147-113,747-47,453-28,634